Novo Nordisk's Karsten Munk Knudsen is targeting 800 million obese people globally.

Shares of Google parent Alphabet slump after quarterly revenue misses analysts’ expectations, AMD’s data-center revenue disappoints, and a report says China is considering a probe into Apple’s App ...

The weight-loss drugmaker's Wegovy and Ozempic are among the most closely watched new medications in recent history, but face serious competition from Eli Lilly’s Zepbound and Mounjaro.

Japan's demand for liquefied natural gas (LNG) may grow by more than 10% to some 74 million metric tons by 2040 under a ...

Novo Nordisk on Wednesday said its new trial of its next-generation obesity drug candidate CagriSema will look at dose ...

The Danish pharmaceutical company expects sales growth to slow this year as capacity constraints, intensifying competition ...

Bloomberg News Now is a comprehensive audio report on today's top stories. Listen for the latest news, whenever you want it, covering global business stories around the world.

French oil major TotalEnergies on Wednesday reported a sharp drop in full-year earnings, against a backdrop of lower crude ...